Benedict Cross

Benedict Cross is the CTO and Head of Platform at PhoreMost, a next-generation drug discovery company based in Cambridge, UK. PhoreMost have developed the SITESEEKER® screening platform which uses engineered mini-proteins to unlock new drug discovery strategies in targeted protein degradation and beyond. Ben is a geneticist and biotechnologist, with research expertise in proteostasis, functional genomics and chemical genetic screening. As a serial biotech platform builder Ben has substantial experience establishing managing business and research alliances across pharma and biotech and leading them to successful outcomes.